122亿!国药控股大合作来了

赛柏蓝
Dec 04

作者 | 晓琳编辑 | 郑瑶国药控股+工业,今年合作动作频繁。01国药控股再次牵手复宏汉霖12月3日,复宏汉霖消息称,将重续与国药控股经销合作,合作期限为2026年1月1日至2028年12月31日。复宏汉霖是一家国际化创新生物制药公司,由复星医药与海外科学家团队在2010年合资组建。企查查信息显示,上海复星新药研究股份有限公司是其最大股东,占比48.94%。从公开资料能够看出,国药控股主要看中的是...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10